A Mechanistic Site-Of-Action Model: A Tool for Informing Right Target, Right Compound, And Right Dose for Therapeutic Antagonistic Antibody Programs.

导出 LinkOut

翻译打印收藏纠错

作者： Georgi I,Kapitanov ^[1] ; Jeffrey R,Chabot ^[1] ; Jatin,Narula ^[1] ; Mahua,Roy ^[1] ; Hendrik,Neubert ^[2] ; Joe,Palandra ^[2] ; Vahid,Farrokhi ^[2] ; Jay S,Johnson ^[2] ; Robert,Webster ^[1] ; Hannah M,Jones ^[1]

作者单位： BioMedicine Design, Pfizer Worldwide R&D, Cambridge, MA, United States. ^[1] BioMedicine Design, Pfizer Worldwide R&D, Andover, MA, United States. ^[2]

关键词 LC-MS PKPD QSP modeling and simulation site of action

DOI 10.3389/fbinf.2021.731340

PMID 36303796

发布时间 2022-10-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in bioinformatics

2021年1卷

731340页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Mechanistic Site-Of-Action Model: A Tool for Informing Right Target, Right Compound, And Right Dose for Therapeutic Antagonistic Antibody Programs.

Frontiers in bioinformatics

相似文献

Frontiers in bioinformatics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Mechanistic Site-Of-Action Model: A Tool for Informing Right Target, Right Compound, And Right Dose for Therapeutic Antagonistic Antibody Programs.

Frontiers in bioinformatics

相似文献

Frontiers in bioinformatics

相关期刊

检索历史清除